Clinical trial · Observational
Advanced MRI Sequences for Radiation Therapy Treatment Planning
Investigation on the Utility of Advanced MRI Imaging Methods for Radiation Therapy Treatment Planning
NCT02340715CI-TRIAL-00030143completedResults postedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to determine if it would be helpful to use advanced MRI imaging techniques to take additional views of the tumor target for radiation treatment planning or treatment follow-up MRI.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (1)
- label
- MRI for treatment planning or follow up
- description
- MRI for treatment planning for radiation therapy or those who have completed treatment and are receiving follow up care.
Primary outcomes (1)
- measure
- Number of Participants Successfully Contributing MRI Data
- timeFrame
- up to 4 weeks from imaging
- description
- We tested these Advanced MR protocols to evaluate which ones would best visualize the target region. This helped us determine the optimum MR SIM protocols for different sites that became clinical standard.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 89 Years
Show eligibility criteria text
Inclusion Criteria: * Patients aged 18 years older of any race or gender with anal canal, brain, breast, cervix, esophagus, gynecology, head and neck, lung, pancreas, primary liver or liver metastases, prostate cancer or sarcoma either undergoing MRI scan for radiation treatment planning or a post treatment MRI * Voluntarily signs an IRB approved consent form Exclusion Criteria: * Inability to obtain informed consent from the patient or their medical power of attorney * Patients who are not undergoing MR for radiation treatment planning * Patients who will not have MRI scans after treatment * Patients with pacemakers or other non-MRI compatible metallic implants * Pregnant women, by self report using a standard MRI questionnaire * Patients who will not receive contrast agent as part of their standard MR, will participate only in the non-contrast portion of the study
References
Publications (1)
- BACKGROUNDKhoo VS, Dearnaley DP, Finnigan DJ, Padhani A, Tanner SF, Leach MO. Magnetic resonance imaging (MRI): considerations and applications in radiotherapy treatment planning. Radiother Oncol. 1997 Jan;42(1):1-15. doi: 10.1016/s0167-8140(96)01866-x. PMID 9132820